Clinical Trial

Effects of Hyaluronic Acid for Subdeltoid Bursitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: with either cross-linked hyaluronic acid or non-crossed-linked hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.
Protocol Amendment History 3 changes
critical Trial status changed: Active, Not Recruiting → Not Yet Recruiting 2026-07-30
notable Primary completion pushed: 2026-07-31 -> 2026-12-31 2026-07-30
minor Completion pushed: 2026-07-31 -> 2026-12-31 2026-07-30
Trial Details
NCT Number NCT07729527
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions Subdeltoid Bursitis of the Shoulder
Enrollment 50 participants
Start Date 2026-07-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29